SOURCE: Industrial Info Resources

Industrial Info Resources

January 29, 2016 07:30 ET

Good Medicine: Pharmaceutical-Biotech Sector New Site Build Construction Investment Nears $20 Billion, an Industrial Info News Alert

SUGAR LAND, TX--(Marketwired - Jan 29, 2016) - Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- As the global economic headache spirals into a migraine, the pharmaceutical-biotech industry capital injection is just what the doctor ordered. There is no shortage of grassroot construction within the industry, as a recent analysis of reported projects (Industrial Info Resources Pharmaceutical Biotech database) revealed 191 sites scattered across the globe translating into a potential total investment value (TIV) of $19.7 billion.

Within this article: Details of pharmaceutical-biotech industry grassroot investments, such as those by Novo Nordisk AS (NYSE:NVO).

For details, view the entire article by subscribing to Industrial Info's Premium Industry News, or browse other breaking industrial news stories at

Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, five offices in North America and 10 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the "Contact Us" page.

Contact Information

  • Contact:
    Brian Ford
    (713) 980-9393